Cancer metabolism and glucose
Pro Research Analysisby 
Searched over 200M research papers
Glucose Metabolism in Cancer: The Warburg Effect and Tumor Growth
Cancer cells often change how they use glucose, favoring a process called aerobic glycolysis, also known as the Warburg effect. In this process, cancer cells take up more glucose and convert it to lactate, even when oxygen is available and their mitochondria are working. This shift supports rapid cell growth, helps cancer cells survive in low-oxygen environments, and provides building blocks for new cells 1235+4 MORE.
Key Enzymes and Transporters in Cancer Glucose Metabolism
Cancer cells increase the activity of glucose transporters (like GLUT) and glycolytic enzymes (such as hexokinase, lactate dehydrogenase, and enolase). These changes are seen in many cancers, including breast and pancreatic cancer, and are linked to cancer progression, metastasis, and poor prognosis 1468+1 MORE. The upregulation of these enzymes and transporters is often driven by oncogenes and tumor suppressors, including HIF-1, Myc, p53, and the PI3K/Akt/mTOR pathway 17.
Consequences of Increased Glucose Metabolism in Cancer
The high rate of glycolysis in cancer cells leads to increased acid production (mainly lactate), which helps cancer cells invade surrounding tissues and resist the body’s defenses. This acidification of the tumor environment gives cancer cells an evolutionary advantage over normal cells . The lactate produced is not just a waste product; it also plays a key role in cancer progression and metastasis, making enzymes like lactate dehydrogenase potential biomarkers for prognosis 13.
Glucose Metabolism and Therapy Resistance
Altered glucose metabolism is closely linked to resistance to chemotherapy. Cancer cells use the energy and intermediates from glycolysis to fuel drug efflux and detoxification, making them less sensitive to treatments. This is especially true in aggressive cancers like triple-negative breast cancer 46. Targeting glucose metabolism with inhibitors or combining them with standard therapies can help overcome this resistance 478.
Targeting Glucose Metabolism for Cancer Diagnosis and Treatment
Because cancer cells rely so heavily on altered glucose metabolism, targeting glycolytic enzymes and transporters is a promising strategy for cancer therapy. Several drugs that inhibit glucose metabolism are in development or have been approved, and combining these with other treatments may improve outcomes 3578. Natural products and phytochemicals that affect glucose metabolism are also being explored as potential therapies 48. Additionally, glucose metabolism markers are being used for cancer imaging and as diagnostic and prognostic tools 13610.
Tumor Microenvironment and Metabolic Crosstalk
Cancer cells interact with surrounding stromal and immune cells, exchanging metabolites and further supporting tumor growth and survival. This metabolic crosstalk, sometimes called the reverse Warburg effect, adds another layer of complexity to cancer metabolism and offers additional targets for therapy 69.
Conclusion
Reprogramming of glucose metabolism is a hallmark of cancer, supporting tumor growth, metastasis, and therapy resistance. Key enzymes and transporters involved in glycolysis are valuable as diagnostic markers and therapeutic targets. Targeting glucose metabolism, alone or in combination with other treatments, holds promise for improving cancer outcomes and overcoming drug resistance. Ongoing research and clinical trials are focused on refining these strategies for better patient care 1345+3 MORE.
Sources and full results
Most relevant research papers on this topic